Ashok Dhanrajgir
Direktor/Vorstandsmitglied bei ImmunoBiology Ltd.
Ursprung des Netzwerks ersten Grades von Ashok Dhanrajgir
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Inventages Venture Capital Investment, Inc
 Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture Capital Investment, Inc (Inventages Venture) is a venture capital firm founded in 2000 by Gunnar Carsten Weikert. The firm is headquartered in Nassau with an additional office in London.
16
| Private Company | Investment Managers | 16 |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
ImmunoBiology Ltd.
 ImmunoBiology Ltd. BiotechnologyHealth Technology ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom.
7
| Holding Company | Biotechnology | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ashok Dhanrajgir
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| NOVAVAX, INC. | Biotechnology | Chairman | |
| NESTLÉ S.A. | Food: Major Diversified | Chief Executive Officer Sales & Marketing | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Director/Board Member | |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| The American University of Rome | College/University | Doctorate Degree | |
Cognoptix, Inc.
 Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Hospital/Nursing Management | Chairman Director/Board Member | |
| TIGENIX NV | Medical Specialties | Director/Board Member Director/Board Member | |
CLIC Sargent
 CLIC Sargent Miscellaneous Commercial ServicesCommercial Services CLIC Sargent operates as an cancer charity for children’s, young people and families. The company was founded in 2005 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
MycoTechnology, Inc.
 MycoTechnology, Inc. Food: Major DiversifiedConsumer Non-Durables MycoTechnology, Inc. is a food technology company, which engages in the development and delivering of fermentation process using gourmet fungi to transform agricultural products to improve taste, value, and health. Its products include ClearTaste and PureTaste. The company was founded by Alan D. Hahn, Pete Lubar, Jim Langan, and Brooks J. Kelly in 2013 and is headquartered in Aurora, CO. | Food: Major Diversified | Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Graduate Degree | |
PA Consulting Group Ltd.
 PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Aberdeen | College/University | Undergraduate Degree | |
Picker International, Inc.
 Picker International, Inc. Building ProductsProducer Manufacturing Part of Cornhill Corp. LLP, Picker International, Inc. is an American company that manufactures heating equipment. | Building Products | Corporate Officer/Principal | |
| University of Cambridge | College/University | Corporate Officer/Principal Doctorate Degree | |
Quadrant Healthcare Plc
 Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Pharmaceuticals: Major | Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
| New York University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Padua | College/University | Doctorate Degree | |
| Cranfield University | College/University | Masters Business Admin | |
| University of Birmingham | College/University | Undergraduate Degree Undergraduate Degree | |
SelectX Pharmaceuticals, Inc.
 SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of Utrecht | College/University | Doctorate Degree Graduate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| King's College London | College/University | Graduate Degree | |
| Beecham Pharmaceuticals | Corporate Officer/Principal | ||
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
CM&D Pharma Ltd.
 CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Celltech Ltd.
 Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| Apcel Ltd. | Corporate Officer/Principal | ||
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Grain Management LLC
 Grain Management LLC Investment ManagersFinance Grain Management LLC (Grain Management) is a private equity firm founded in 2007 by David Grain. The firm is headquartered in Washington, Columbia. | Investment Managers | Corporate Officer/Principal | |
Memo Therapeutics AG
 Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Chief Executive Officer | |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman Chairman | |
| LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member Founder Director/Board Member | |
PeakBridge Partners Ltd
 PeakBridge Partners Ltd Investment ManagersFinance PeakBridge Partners Ltd (PeakBridge Partners) is a venture capital firm founded in 2017 by Erich Sieber and Nadav Berger. The firm is headquartered in Valletta, Malta. | Investment Managers | Founder Consultant / Advisor | |
CLIC Sargent Cancer Care for Children
 CLIC Sargent Cancer Care for Children Miscellaneous Commercial ServicesCommercial Services CLIC Sargent Cancer Care for Children provides cancer charity and support services for children, young people, and families. The non-profit company is based in Bristol, UK. The British company was founded in 2005. Kate Lee has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
Tridek-One Therapeutics SAS
 Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 17 |
| Vereinigte Staaten | 13 |
| Frankreich | 6 |
| Schweiz | 5 |
| Niederlande | 5 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 13 |
| Commercial Services | 7 |
| Finance | 4 |
| Consumer Non-Durables | 3 |
Operativ
| Director/Board Member | 165 |
| Corporate Officer/Principal | 47 |
| Chairman | 39 |
| Private Equity Investor | 35 |
| Chief Executive Officer | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Russell Greig | 31 |
| Rémi Droller | 29 |
| Guido Magni | 23 |
| Robert Schier | 20 |
| Joël Jean-Mairet | 17 |
| Geert-Jan Mulder | 17 |
| Klaus Breiner | 16 |
| Rita Jain | 14 |
| Edwin de Graaf | 14 |
| Erik van den Berg | 13 |
| Gunnar Carsten Weikert | 13 |
| John A. Lambert | 13 |
| Erich Sieber | 13 |
| Graham Clarke | 12 |
| Gertrude Allen | 11 |
- Börse
- Insiders
- Ashok Dhanrajgir
- Unternehmensverbindungen
